Denosumab improves bone mineral density and microarchitecture and reduces bone pain in women with osteoporosis with and without glucocorticoid treatment.

Biotechnol Biotechnol Equip · 2014 · PMC4434053 · PMID 26019600

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

The one-year clinical experience presented herein showed a clear trend for increase of BMD in the two groups that were managed: the GCT and non-GCT groups.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.